Updates on PARP Inhibition

from PharmaTalkRadio · host Conference Forum

In this podcast, first recorded at the 4th annual IO Combinations 360° conference, Dr Darren Hodgson, AstraZeneca presented updates on PARP inhibition. Topics include: Strategies to target homologous recombination repair deficiencyMonotherapy indications and current development landscapeScientific hypotheses being explored in olaparib combinations To learn more about the upcoming IO Combinations 360° conference please visit, www.iocombinations360.com

Episode metadata supplied by the publisher feed · Published Mar 9, 2020

Embed this episode

Attribution link and audio player

Ready to play

Updates on PARP Inhibition

0:00 24:46

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of PharmaTalkRadio?

This episode is 24 minutes long.

When was this PharmaTalkRadio episode published?

This episode was published on March 9, 2020.

Can I download this PharmaTalkRadio episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!